Roche Holding AG - Asset Resilience Ratio

Latest as of December 2025: 15.37%

Roche Holding AG (ROG) has an Asset Resilience Ratio of 15.37% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CHF15.48 Billion

≈ $19.57 Billion USD Cash + Short-term Investments

Total Assets

CHF100.70 Billion

≈ $127.32 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (1998–2025)

This chart shows how Roche Holding AG's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Roche Holding AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF5.58 Billion	5.54%
Short-term Investments	CHF9.89 Billion	9.82%
Total Liquid Assets	CHF15.48 Billion	15.37%

Asset Resilience Insights

Good Liquidity Position: Roche Holding AG maintains a healthy 15.37% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Roche Holding AG Industry Peers by Asset Resilience Ratio

Compare Roche Holding AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC F:ZEGA	Drug Manufacturers - General	0.03%
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	Drug Manufacturers - General	9.91%
Hangzhou Minsheng Healthcare Co Ltd SHE:301507	Drug Manufacturers - General	24.96%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
Amarin Corporation PLC NASDAQ:AMRN	Drug Manufacturers - General	25.04%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for Roche Holding AG (1998–2025)

The table below shows the annual Asset Resilience Ratio data for Roche Holding AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.32%	CHF11.40 Billion ≈ $14.42 Billion	CHF100.70 Billion ≈ $127.32 Billion	-1.63pp
2024-12-31	12.95%	CHF13.19 Billion ≈ $16.67 Billion	CHF101.80 Billion ≈ $128.70 Billion	+5.87pp
2023-12-31	7.08%	CHF6.41 Billion ≈ $8.10 Billion	CHF90.47 Billion ≈ $114.38 Billion	-0.77pp
2022-12-31	7.86%	CHF6.93 Billion ≈ $8.76 Billion	CHF88.15 Billion ≈ $111.45 Billion	-0.81pp
2021-12-31	8.67%	CHF8.00 Billion ≈ $10.12 Billion	CHF92.32 Billion ≈ $116.71 Billion	-0.38pp
2020-12-31	9.05%	CHF7.80 Billion ≈ $9.86 Billion	CHF86.14 Billion ≈ $108.90 Billion	+0.54pp
2019-12-31	8.52%	CHF7.08 Billion ≈ $8.95 Billion	CHF83.09 Billion ≈ $105.05 Billion	-2.91pp
2018-12-31	11.42%	CHF8.97 Billion ≈ $11.34 Billion	CHF78.52 Billion ≈ $99.27 Billion	+0.24pp
2017-12-31	11.19%	CHF8.58 Billion ≈ $10.84 Billion	CHF76.68 Billion ≈ $96.94 Billion	+3.63pp
2016-12-31	7.55%	CHF5.80 Billion ≈ $7.34 Billion	CHF76.82 Billion ≈ $97.12 Billion	+0.37pp
2015-12-31	7.18%	CHF5.44 Billion ≈ $6.88 Billion	CHF75.76 Billion ≈ $95.78 Billion	-3.36pp
2014-12-31	10.54%	CHF7.96 Billion ≈ $10.06 Billion	CHF75.54 Billion ≈ $95.50 Billion	-2.23pp
2013-12-31	12.76%	CHF7.93 Billion ≈ $10.03 Billion	CHF62.17 Billion ≈ $78.60 Billion	-1.84pp
2012-12-31	14.60%	CHF9.46 Billion ≈ $11.96 Billion	CHF64.81 Billion ≈ $81.93 Billion	+2.53pp
2011-12-31	12.07%	CHF7.43 Billion ≈ $9.40 Billion	CHF61.58 Billion ≈ $77.85 Billion	-2.78pp
2010-12-31	14.85%	CHF9.06 Billion ≈ $11.45 Billion	CHF61.02 Billion ≈ $77.15 Billion	-6.75pp
2009-12-31	21.60%	CHF16.11 Billion ≈ $20.36 Billion	CHF74.56 Billion ≈ $94.27 Billion	+0.76pp
2008-12-31	20.84%	CHF15.86 Billion ≈ $20.05 Billion	CHF76.09 Billion ≈ $96.20 Billion	-5.31pp
2007-12-31	26.15%	CHF20.45 Billion ≈ $25.85 Billion	CHF78.18 Billion ≈ $98.84 Billion	-2.23pp
2006-12-31	28.38%	CHF21.12 Billion ≈ $26.70 Billion	CHF74.41 Billion ≈ $94.08 Billion	+4.37pp
2005-12-31	24.01%	CHF16.66 Billion ≈ $21.06 Billion	CHF69.36 Billion ≈ $87.70 Billion	+6.12pp
2004-12-31	17.90%	CHF10.39 Billion ≈ $13.14 Billion	CHF58.08 Billion ≈ $73.42 Billion	-0.29pp
2003-12-31	18.19%	CHF10.82 Billion ≈ $13.68 Billion	CHF59.49 Billion ≈ $75.21 Billion	-1.18pp
2002-12-31	19.37%	CHF12.39 Billion ≈ $15.67 Billion	CHF63.99 Billion ≈ $80.91 Billion	-9.07pp
2001-12-31	28.44%	CHF21.41 Billion ≈ $27.07 Billion	CHF75.29 Billion ≈ $95.18 Billion	+2.43pp
2000-12-31	26.01%	CHF18.09 Billion ≈ $22.87 Billion	CHF69.53 Billion ≈ $87.91 Billion	+2.14pp
1999-12-31	23.87%	CHF16.81 Billion ≈ $21.26 Billion	CHF70.43 Billion ≈ $89.04 Billion	-1.31pp
1998-12-31	25.19%	CHF14.07 Billion ≈ $17.79 Billion	CHF55.88 Billion ≈ $70.65 Billion	--

pp = percentage points

About Roche Holding AG

SW:ROG Switzerland Drug Manufacturers - General

Market Cap

$279.33 Billion

CHF220.94 Billion CHF

Market Cap Rank

#60 Global

#1 in Switzerland

Share Price

CHF320.70

Change (1 day)

+0.79%

52-Week Range

CHF246.30 - CHF374.00

All Time High

CHF374.00